Related Experiment Video
Updated: Aug 7, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
[Cardiac alterations caused by renal failure]
1Klinik für Kardiologie, Pneumologie und Angiologie, Klinikum der Heinrich-Heine-Universität Düsseldorf. schannw@uni-duesseldorf.de
Insights
Cardiac disease is a major concern for patients with end-stage renal disease. Beyond atherosclerosis, heart abnormalities like hypertrophy and fibrosis contribute to myocardial ischemia in uremia.
Area of Science:
- Nephrology and Cardiology
- Uremic Cardiomyopathy
Context:
- End-stage renal disease (ESRD) patients exhibit high cardiovascular mortality.
- Accelerated atherosclerosis was the presumed cause of cardiac deaths.
- Recent studies challenge this assumption, showing myocardial infarction accounts for only 30-50% of cardiac deaths in uremia.
Purpose:
- To explore additional cardiac abnormalities contributing to myocardial ischemia in chronic uremia.
- To investigate factors beyond coronary artery disease in uremic cardiac mortality.
Summary:
- A significant portion (30-40%) of patients with renal insufficiency, angina, and ischemia have normal coronary arteries.
- This suggests non-atherosclerotic mechanisms are involved in cardiac dysfunction.
- Structural changes like left ventricular hypertrophy, interstitial fibrosis, and microvascular disease impact myocardial perfusion reserve.
Impact:
- Highlights the multifactorial nature of cardiac disease in end-stage renal disease.
- Suggests novel therapeutic targets beyond traditional cardiovascular risk management.
- Emphasizes the need to investigate cardiac structural and functional changes in uremic patients.
Abstract:
Cardiac disease is the most common cause of death in patients with endstage renal disease. It was assumed that the high rate of cardiovascular mortality was based on accelerated atherosclerosis. Recently published articles, however, demonstrated that only 30-50% of all cardiac deaths in patients with uremia was due to myocardial infarction. On the other hand 30-40% of all patients with renal insufficiency, angina pectoris and documented ischemia have normal coronary arteries. Therefore, it is suggested that in patients with chronic uremia apart from accelerated atherosclerosis further abnormalities of the heart lead to myocardial ischemia. Recently published papers report functional and structural changes, which affect myocardial perfusion reserve. These structural changes include left ventricular hypertrophy, interstitial myocardial fibrosis, and microvascular disease.
Related Concept Videos
Heart Failure Drugs: Diuretics
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
